in

RIVELİME 15 mg Hard Capsule



Temporary info and prospectus paperwork for RIVELİME 15 mg (Indications, what’s RIVELİME 15 mg drug; what ought to be adopted earlier than beginning the drug, whether or not its use is appropriate for many who are breastfeeding or pregnant; interplay, drawbacks; advantages, storage situations; utilization methodology; RIVELİME dosage, unintended effects It covers the problems that ought to be recognized about RIVELİME 15 mg, akin to what to do in case of undesirable results and proposals.) RIVELİME 15 mg respectively; It’s categorised as Antineoplastic and Immunomodulatory Brokers, Immunosuppressants, Different Immunosuppressants and Lenalidomide, and is among the many licensed medication within the Medicines and Medical Gadgets Company with the ATC code L04AX04. RİVELİME 15 mg, which you’ll get hold of from the pharmacy with a standard prescription, is a product of DEVA HOLDING. Utilization of RİVELİME 15 mg Hard Capsule
The publish RİVELİME 15 mg Hard Capsule first appeared on İlaç Internet.

Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.

You May Also Like:  VOCHERON 8 mg/4 ml IM/IV Solution for Injection/Infusion

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

RIVELİME 25 mg Hard Capsule

RIVELİME 7.5 mg Hard Capsule